NovaBay Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBY and other ETFs, options, and stocks.About NBY
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor.
CEOMichael Kazley
CEOMichael Kazley
Employees14
Employees14
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2000
Founded2000
Employees14
Employees14
NBY Key Statistics
Market cap844.27M
Market cap844.27M
Price-Earnings ratio-9.94
Price-Earnings ratio-9.94
Dividend yield—
Dividend yield—
Average volume2.61M
Average volume2.61M
High today$13.64
High today$13.64
Low today$6.30
Low today$6.30
Open price$11.01
Open price$11.01
Volume2.87M
Volume2.87M
52 Week high$19.95
52 Week high$19.95
52 Week low$0.46
52 Week low$0.46
Stock Snapshot
As of today, NovaBay Pharmaceuticals(NBY) shares are valued at $6.70. The company's market cap stands at 844.27M, with a P/E ratio of -9.94.
During the trading session on 2026-01-20, NovaBay Pharmaceuticals(NBY) shares reached a daily high of $13.64 and a low of $6.30. At a current price of $6.70, the stock is +6.3% higher than the low and still -50.9% under the high.
Trading activity shows a volume of 2.87M, compared to an average daily volume of 2.61M.
Over the past 52 weeks, NovaBay Pharmaceuticals(NBY) stock has traded between a high of $19.95 and a low of $0.46.
Over the past 52 weeks, NovaBay Pharmaceuticals(NBY) stock has traded between a high of $19.95 and a low of $0.46.
People also own
Based on the portfolios of people who own NBY. This list is generated using Robinhood data, and it’s not a recommendation.